prostate-cancer

Documents about prostate-cancer

• Target trial emulation of survival outcomes for clinically localized prostate cancer treatments.#472534NCBI PubMed Central
• Clinical and survival data of 424 prostate cancer patients#486244Harvard Dataverse Dataverse OAI Archive
• Optimal management of oligometastatic prostate cancer: current state and future directions.#615760NCBI PubMed Central
• Determining Barriers to Dietary Change Among Medically Underserved Men With Prostate Cancer.#666175NCBI PubMed Central
• Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy#803070ClinicalTrials.gov
• A Registry of Participants With Prostate Cancer in Asia#829264ClinicalTrials.gov
• PANDA-PLUS-Bench: A Clinical Benchmark for Evaluating the Robustness of AI Foundation Models in Prostate Cancer Diagnosis#390809BYU ScholarsArchive
• Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients#832760ClinicalTrials.gov
• Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients#784372eScholarship
• Multi-omics Profiling Reveals an NF-κB-Driven Anti-apoptotic Network Underlying Resistance to Oncolytic VSV in Prostate Cancer Cells#417342bioRxiv / medRxiv
• Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes#813798ClinicalTrials.gov
• Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment#826896ClinicalTrials.gov
• Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies#234411ClinicalTrials.gov
• Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study.#145825NCBI PubMed Central
• Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan#478773IRIS
• Characteristics and outcomes of men presenting with complications of metastatic prostate cancer.#9409NCBI PubMed Central
• Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.#30825NCBI PubMed Central
• A unique transcriptomic landscape defines African-specific grade group 1 prostate cancer#152324Europe PMC
• Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer#153475PMC Full-Text (OAI)
• Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy#154683ClinicalTrials.gov
• Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment#168085White Rose Research Online
• AKR1C3-PKM2-oxidative phosphorylation axis drives prostate cancer radioresistance via UBE2T upregulation.#174570NCBI PubMed Central
• Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics.#247586NCBI PubMed Central
• Targeting regulatory T cells in the prostate cancer microenvironment: From mechanisms to therapeutics (Review).#275478NCBI PubMed Central
• Propofol-based versus volatile anesthesia and postoperative immune response in prostate cancer.#280949NCBI PubMed Central
• Digital twin technologies in prostate cancer as a frontier for precision medicine.#298779NCBI PubMed Central
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)#321696ClinicalTrials.gov
• Interplay of the 3D genome and epigenome in androgen-driven prostate cancer.#323056NCBI PubMed Central
• The regulatory mechanism and clinical significance of RNA editing in prostate cancer.#326949NCBI PubMed Central
• The evolving PI-RADS paradigm#340183IRIS
• Integrative genomic profiling identifies MLPH as a candidate gene in prostate cancer.#402582NCBI PubMed Central
• AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.#418354NCBI PubMed Central
• Prostate Cancer Management in Nigeria: A mini-review of up-to-date treatment options.#630957NCBI PubMed Central
• Inflammatory bowel disease and prostate cancer: from epidemiological controversy to mechanistic hypotheses.#653360NCBI PubMed Central
• Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy#840301ClinicalTrials.gov
• Performance Evaluation of the AMS CONTINUUM™ Device#842565ClinicalTrials.gov
• Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy#845099ClinicalTrials.gov
• Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade#10075bioRxiv / medRxiv
• Novel computational frameworks for driver gene identification and evolutionary informed genomics analysis in melanoma and prostate cancer#643717Harvard DASH
• A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer#460010ClinicalTrials.gov
• A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer#800552ClinicalTrials.gov
• SMMART Adaptive Clinical Treatment (ACT) Trial#805987ClinicalTrials.gov
• A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA#417546ClinicalTrials.gov
• Network toxicology & molecular docking: endocrine-disrupting chemicals induce prostate cancer - a system study.#30582NCBI PubMed Central
• From pathways to prediction: a comparative machine learning framework for prostate cancer survival.#30691NCBI PubMed Central
• Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome#195530ClinicalTrials.gov
• Convolutional neural networks for prostate cancer detection, classification, and segmentation: A systematic review and bibliometric analysis#243424AVESIS
• Multi-regional Multiparametric Deep Learning Radiomics for Diagnosis of Clinically Significant Prostate Cancer.#258390NCBI PubMed Central
• Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis.#288986NCBI PubMed Central
• Relationship Values and Committed Actions Among Couples Coping with Prostate Cancer: A Qualitative Study.#364548NCBI PubMed Central